Infection Groups Differential (IGD) Score Reveals Infection Ability Difference between SARS-CoV-2 and Other Coronaviruses
This article has been Reviewed by the following groups
Discuss this preprint
Start a discussion What are Sciety discussions?Listed in
- Evaluated articles (ScreenIT)
Abstract
The Corona Virus Disease 2019 (COVID-19) pandemic that began in late December 2019 has resulted in millions of cases diagnosed worldwide. Reports have shown that SARS-CoV-2 shows extremely higher infection rates than other coronaviruses. This study conducted a phylogenetics analysis of 91 representative coronaviruses and found that the functional spike protein of SARS-CoV-2, which interacts with the human receptor ACE2, is actually not undergoing distinct selection pressure compared to other coronaviruses. Furthermore, we define a new measurement, infection group differential (IGD) score, in assessing the infection ability of two human coronavirus groups. There are nine extremely high IGD (ehIGD) sites in the receptor-binding domain (RBD) out of 40 high IGD (hIGD) sites that exhibit a unique infection-related pattern from the haplotype network and docking energy comparison. These 40 hIGD sites are basically conserved among the SARS-CoV-2, i.e. there are only two hIGD sites mutated in four out of 1,058 samples, defined as rare-mutation hIGD (rhIGD) sites. In conclusion, ehIGD and rhIGD sites might be of great significance to the development of vaccines.
Article activity feed
-
SciScore for 10.1101/2020.05.12.090324: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
NIH rigor criteria are not applicable to paper type.Table 2: Resources
Software and Algorithms Sentences Resources Homologous sequence searching of SARS-like coronaviruses spike protein was first performed by BLASTP (v 2.2.29+) [14] in NR (Non-Redundant Protein Sequence Database), and 868 sequences were selected under the condition of sequence length > 600 aa and a sequence identity > 30%. BLASTPsuggested: (BLASTP, RRID:SCR_001010)Phylogenetic analysis: The DNA sequences of whole genome and related protein sequences of 91 coronaviruses were aligned using mafft v7.455 [15], and the result multiple sequence was trimmed for poorly aligned positions with Gblock 0.91b [16]. mafftsuggested: (MAFFT, RRID:SCR_01…SciScore for 10.1101/2020.05.12.090324: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
NIH rigor criteria are not applicable to paper type.Table 2: Resources
Software and Algorithms Sentences Resources Homologous sequence searching of SARS-like coronaviruses spike protein was first performed by BLASTP (v 2.2.29+) [14] in NR (Non-Redundant Protein Sequence Database), and 868 sequences were selected under the condition of sequence length > 600 aa and a sequence identity > 30%. BLASTPsuggested: (BLASTP, RRID:SCR_001010)Phylogenetic analysis: The DNA sequences of whole genome and related protein sequences of 91 coronaviruses were aligned using mafft v7.455 [15], and the result multiple sequence was trimmed for poorly aligned positions with Gblock 0.91b [16]. mafftsuggested: (MAFFT, RRID:SCR_011811)RAxML v8.2.12 [17] was used to build the maximum likelihood phylogenetic tree of genomes with the parameters “-m GTRCAT” and protein with the parameters “-m PROTGAMMAILGX”. RAxMLsuggested: (RAxML, RRID:SCR_006086)Codon usage bias analysis: Condonw v1.3 [19] was used to calculate the universal index value of each codon of the Cds of coronavirus functional protein. Condonwsuggested: NoneKa/Ks analysis: Ka/KS ratios were calculated using KaKs_Calculator 2.0 [20] and used in the analysis of selection pressure. KaKs_Calculatorsuggested: NoneHaplotype network analysis: DnaSP v6.12.03 [21] was used to generate multi-sequence aligned haplotype data. DnaSPsuggested: (DnaSP, RRID:SCR_003067)Arlequin v3.5.2.2 [22] was used to estimate haplotype frequency. Arlequinsuggested: (ARLEQUIN, RRID:SCR_009051)Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).
Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- No funding statement was detected.
- No protocol registration statement was detected.
-
